Clinical trials
Phase 3 Immune System Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 3 |
| Eli Lilly and Company | 2 |
| National Center for Research Resources (NCRR) | 2 |
| Pfizer | 2 |
| Ariad Pharmaceuticals | 1 |
| Baxalta now part of Shire | 1 |
| Biogen | 1 |
| Bristol-Myers Squibb | 1 |
| Ellodi Pharmaceuticals, LP | 1 |
| La Jolla Pharmaceutical Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 20 |
| Autoimmune Diseases | 9 |
| Connective Tissue Diseases | 5 |
| Hypersensitivity | 5 |
| Hypersensitivity, Immediate | 5 |
| Lupus Erythematosus, Systemic | 5 |
| Communicable Diseases | 3 |
| Dermatitis, Atopic | 3 |
| Eczema | 3 |
| Genetic Diseases, Inborn | 3 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.